PubMed:23530032 / 1494-1904 JSONTXT

{"project":"sentences","denotations":[{"id":"T17","span":{"begin":0,"end":410},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-κB ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T31","span":{"begin":11,"end":22},"obj":"http://purl.obolibrary.org/obo/MAT_0000084"},{"id":"T32","span":{"begin":11,"end":15},"obj":"http://purl.obolibrary.org/obo/MAT_0000299"}],"text":"In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-κB ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio."}

{"project":"Allie","denotations":[{"id":"SS1_23530032_16_0","span":{"begin":280,"end":314},"obj":"expanded"},{"id":"SS2_23530032_16_0","span":{"begin":316,"end":321},"obj":"abbr"},{"id":"SS1_23530032_16_1","span":{"begin":364,"end":379},"obj":"expanded"},{"id":"SS2_23530032_16_1","span":{"begin":381,"end":384},"obj":"abbr"}],"relations":[{"id":"AE1_23530032_16_0","pred":"abbreviatedTo","subj":"SS1_23530032_16_0","obj":"SS2_23530032_16_0"},{"id":"AE1_23530032_16_1","pred":"abbreviatedTo","subj":"SS1_23530032_16_1","obj":"SS2_23530032_16_1"}],"text":"In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-κB ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio."}

{"project":"PMID_GLOBAL","denotations":[{"id":"T6","span":{"begin":11,"end":22},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"}],"text":"In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-κB ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio."}

{"project":"Anatomy-MAT","denotations":[{"id":"T33","span":{"begin":11,"end":22},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"mat_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MAT_0000084"}],"text":"In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-κB ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio."}

{"project":"mondo_disease","denotations":[{"id":"T8","span":{"begin":38,"end":41},"obj":"Disease"},{"id":"T9","span":{"begin":203,"end":206},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0043797"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0043797"}],"text":"In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-κB ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T58","span":{"begin":11,"end":27},"obj":"Body_part"},{"id":"T59","span":{"begin":66,"end":77},"obj":"Body_part"},{"id":"T60","span":{"begin":119,"end":129},"obj":"Body_part"},{"id":"T61","span":{"begin":217,"end":227},"obj":"Body_part"}],"attributes":[{"id":"A58","pred":"uberon_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CL_0002092"},{"id":"A59","pred":"uberon_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/CL_0000092"},{"id":"A60","pred":"uberon_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/CL_0000092"},{"id":"A61","pred":"uberon_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/CL_0000062"}],"text":"In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-κB ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio."}

{"project":"Glycosmos15-CL","denotations":[{"id":"T3","span":{"begin":11,"end":27},"obj":"Cell"},{"id":"T4","span":{"begin":66,"end":77},"obj":"Cell"},{"id":"T5","span":{"begin":119,"end":129},"obj":"Cell"},{"id":"T6","span":{"begin":217,"end":227},"obj":"Cell"}],"attributes":[{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0002092"},{"id":"A4","pred":"cl_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL:0000092"},{"id":"A5","pred":"cl_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CL:0000092"},{"id":"A6","pred":"cl_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CL:0000062"}],"text":"In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-κB ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio."}